Peem Lorvidhaya, MD
Clinical Cardiac Electrophysiology · Fredericksburg, VANPI 1346371184
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $218,527 of the $230,393 with a category attached, or 94.8%. Boehringer Ingelheim accounts for 60.9% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $146,707 and has fallen 78.4% since, to $31,707 in 2025. Among clinical cardiac electrophysiology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $921.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$140K
- Biosense Webster, Inc.$65K
- Abbott$16K
- Johnson & Johnson$4K
- Biotronik Inc.$2K
- Braemar Manufacturing, LLC$540
- plus $2K from 22 others
Across 49 payments — averaging $160.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$6K
- Abbott$2K
What the payments were for
- Consulting fees$218,52795%
- Speaking & faculty fees$4,1402%
- Travel & lodging$2,8931%
- Food & beverage$4,8232%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 13 | $140,224 |
| Biosense Webster, Inc. | 52 | $65,138 |
| Abbott | 66 | $16,318 |
| Johnson & Johnson(2 entities) | 23 | $3,973 |
| Biotronik Inc. | 9 | $2,034 |
| Braemar Manufacturing, LLC | 1 | $540 |
| Medtronic(2 entities) | 10 | $457 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $370 |
| Boston Scientific | 14 | $269 |
| Impulse Dynamics (USA) Inc. | 2 | $169 |
| Novartis | 10 | $157 |
| Philips North America LLC | 5 | $95 |
| Cardiva Medical, Inc. | 4 | $85 |
| Sanofi-aventis U.S. LLC | 4 | $72 |
| Amgen | 4 | $65 |
| AstraZeneca | 3 | $63 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Heartflow, Inc. | 2 | $43 |
| Baxter Healthcare | 1 | $41 |
| Atricure, Inc. | 2 | $40 |
| Irhythm Technologies, Inc. | 1 | $30 |
| Penumbra, Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Recor Medical Inc | 1 | $26 |
| Pfizer | 2 | $26 |
| Cvrx, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SmartAblateTM System RF Generator$64,607
- ENSITE PRECISION$9,777
- XARELTO$3,820
- EnSite Precision Cardiac Mapping System$1,727
- ADVISOR$1,559
- AMPLATZER AMULET$1,454
- ENSITE$750
- Cardiac Monitoring Suite$540
- OPTIMIZER$259
- PulseSelect$136
- Carto 3$105
How this compares
$230,393 in reported general payments places this provider in the 95th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 128 | $103,375 |
| EntrestoSacubitril/Valsartan | 15 | $16,486 |
| Repatha SyringeEvolocumab | 21 | $6,595 |
| Flecainide Acetate | 97 | $4,169 |
| Colchicine | 28 | $2,609 |
| Midodrine Hcl | 20 | $2,117 |
| Spironolactone | 211 | $1,195 |
| Losartan Potassium | 204 | $1,184 |
| Metoprolol Succinate | 62 | $857 |
| Rosuvastatin Calcium | 74 | $656 |
| Carvedilol | 39 | $269 |
| Atorvastatin Calcium | 23 | $240 |
| Pantoprazole Sodium | 24 | $236 |
| Amlodipine Besylate | 50 | $175 |
| Metoprolol Tartrate | 14 | $170 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $26 | $103,375128 claims |
| NovartisEntresto | $157 | $16,48615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Fredericksburg
- Ashok TalrejaFredericksburg$32K
- Hakeem AyindeFredericksburg$26K
- Kenneth EllenbogenRichmond$360K
- Brett AtwaterFairfax$319K
- Oliver MonfrediCharlottesville$231K
- Erich KiehlNewport News$181K
- Emmanuel EkanemWinchester$132K
- Pamela MasonCharlottesville$130K
- Ajay PillaiRichmond$129K
- Stephen GaetaFairfax$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.